⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

EIKN News

Eikon Therapeutics, Inc. Common Stock

Eikon Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Clinical and Corporate Updates